Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Junji Furuse et al.|The Lancet|2023Cited by 1k
Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE TrialKerry S. Courneya, Christopher M. Booth, Janette L. Vardy et al.|Cancer Epidemiology Biomarkers & Prevention|2016Cited by 115